Negara: Armenia
Bahasa: Inggris
Sumber: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
bendamustine hydrochloride
Accord Healthcare Limited
L01AA09
bendamustine hydrochloride
2.5mg/ml
powder for concentrate for solution for infusion
(1) and (5) glass vial 50ml
Prescription
Registered
2018-02-07
PACKAGE LEAFLET: INFORMATION FOR THE USER BENDAMUSTINE HYDROCHLORIDE 2.5 MG / ML POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION Bendamustine hydrochloride The name of your medicine is Bendamustine hydrochloride 2.5 mg/ml powder for concentrate for solution for infusion’ but in the rest of the leaflet it will be called “Bendamustine hydrochloride”. Read all of this leaflet carefully before you start using this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or healthcare professional. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Bendamustine hydrochloride is and what it is used for 2. What you need to know before you use Bendamustine hydrochloride 3. How to use Bendamustine hydrochloride 4. Possible side effects 5. How to store Bendamustine hydrochloride 6. Contents of the pack and other information 1. WHAT BENDAMUSTINE HYDROCHLORIDE IS AND WHAT IT IS USED FOR Bendamustine hydrochloride is a medicine which is used for the treatment of certain types of cancer (cytotoxic medicine). Bendamustine hydrochloride is used alone (monotherapy) or in combination with other medicines for the treatment of the following forms of cancer: - chronic lymphocytic leukaemia in cases where fludarabine combination chemotherapy is not appropriate for you, - non-Hodgkin lymphomas, which had not, or only shortly, responded to prior rituximab treatment, - multiple myeloma in cases where high-dose chemotherapy with autologous stem cell transplantation, thalidomide or bortezomib containing therapy is not appropriate for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE BENDAMUSTINE HYDROCHLORIDE Do not use Bendamustine hyd Baca dokumen lengkapnya